Since the COVID-19 shelter-in-place orders were announced across the US in March, the use of virtual care technologies for patient visits within ambulatory clinics has increased from under 10% to over 70%. During the first weeks of March, providers scrambled to simply find any virtual care technologies to help keep their “doors” open to their patients.
Last week, Practice Fusion, an electronic health records (EHR) company, was fined $145 million for setting up a business arrangement that violated the federal Anti-Kickback Statute. This law prevents anyone from offering, soliciting, paying, or receiving anything of value in order to induce referrals or generate federal healthcare business.
Remote patient monitoring (RPM) devices – fitness watches, blood pressure, cardio monitors – are growing in popularity as a way to gather and correlate data outside of a traditional clinical setting and share up-to-the-minute data with care providers.
2020 looks to a landmark year for finalized regulations dictating how health data can be exchanged. Health technology entrepreneurs must understand the regulatory landscape of how care can profitably be delivered.
Almost a third of the US population will travel during the holidays. With flu season already in full swing, tracking flu outbreaks is vital to caregivers of small children and the elderly, in addition to those with compromised immunity.
Are you building an application that allows an individual or a provider a comprehensive view of a person’s health care journey? Have you run into data access barriers when trying to link into a person’s health data from a hospital system’s electronic health record (EHR) system? The federal government will soon release new rules that may open access to this coveted data – helping you provide a fuller value to your company’s digital health solution.
With almost 20% of our nation’s GDP tied to health care, an often complex and convoluted sector, it is an exciting time, ripe with opportunities to disrupt the status quo and create tech-enabled efficiencies for large scale profit.
The buzz around social determinants of health (SDoH) data is growing. Business leaders need to think through the return on investment (ROI) for incorporating SDoH data capabilities into your platform, product or service.
Health tech disruptors creating in-home monitoring and wearable technologies that collect health data may be interested to know that the FDA is getting into the business of what they call “Real World Data (RWD).” RWD is data, often collected directly from the user or patient and provides information on their health beyond a clinical encounter, like a visit to the doctor. This month the FDA awarded over $200 million to fund the next five years of their drug surveillance data program, The Sentinel Initiative.
This February, draft federal rules on health data interoperability, information blocking, health IT certification, and health data exchange related to Medicare/Medicaid conditions of participation were proposed by the Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health IT (ONC). After releasing these proposed new rules CMS and ONC opened the field to comments and questions from interested and invested parties such as health care companies, providers, and current and future patients.
